PLB-002

· Primelink BioTherapeitics(ShenZhen) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLB-002, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PLB-002 in Advanced Solid Tumors [Phase 1]